Design and fabrication of a dual-mode colorimetric nanobiosensor for detection of breast cancer-related microRNA biomarkers upon the simultaneous application of gold nanoparticles and DNAzyme
Analytica Chimica Acta · 2026-08 · 1412 · 345654
DOI: 10.1016/j.aca.2026.345654 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytica Chimica Acta, 2026-08. Verfasst von Maryam Keramati und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nanobiotechnology and Biomimetics, School of Life Science Engineering, College of Interdisciplinary Science and Technology, University …. Hauptthemen laut MEDLINE: MicroRNAs, Gold, Metal Nanoparticles, Colorimetry. Die Arbeit nennt 56 Literaturangaben. Gefördert von: Iran National Science Foundation, Iran Nanotechnology Innovation Council, University of Tehran.
Abstract (Originalsprache)
BACKGROUND Breast cancer is among the most prevalent malignancies worldwide, and early diagnosis is essential to improve treatment efficacy. In this study, we developed a dual signal colorimetric nanobiosensor for the simultaneous detection of two breast cancer-related microRNAs, miR-145 and miR-21. METHODS The nanobiosensor utilizes target-triggered hybridization chain reaction (HCR) to form G-quadruplex DNAzymes for miR-145 detection via OPD oxidation (at 425 nm). For miR-21, target-induced hybridization leads to aggregation of gold nanoparticles (AuNPs) and the absorbance peak at 535 nm. In multiplexed analysis, miR-145 contributes to both signals, while miR-21 specifically affects the 535 nm absorbance, enabling simultaneous quantification. RESULTS The nanobiosensor demonstrated excellent sensitivity and specificity for detecting target microRNAs, achieving limits of detection (LOD) as low 0.15 nM for miR-145 and 0.12 nM for miR-21. Strong linear correlations were observed, with R2 values of 0.9887 for miR-145 and 0.9711 for miR-21. The nanobiosensor effectively distinguished target microRNAs both individually and simultaneously, while miR-195 and miR-155 were used as non-targets to validate its high specificity. SIGNIFICANCE In experiments involving the co-detection of both targets, the nanobiosensor achieved LODs in the range of 0.01-0.4 nM, wich further confirmed the nanobiosensor's stability and efficient multiplex detection capability. In conclusion, the developed dual-miRNA detection platform offers a powerful assay for the early screening of breast cancer and demonstrates strong potential for application in clinical multiplex diagnostic assays.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nanobiotechnology and Biomimetics, School of Life Science Engineering, College of Interdisciplinary Science and Technology, University of Tehran, Tehran, 14399-57131, Iran.
- Department of Nanobiotechnology and Biomimetics, School of Life Science Engineering, College of Interdisciplinary Science and Technology, University of Tehran, Tehran, 14399-57131, Iran. Electronic address: mrahaie@ut.a…
Förderung
- Iran National Science Foundation
- Iran Nanotechnology Innovation Council
- University of Tehran
Zitieren
APA
Keramati, M., & Rahaie, M. (2026). Design and fabrication of a dual-mode colorimetric nanobiosensor for detection of breast cancer-related microRNA biomarkers upon the simultaneous application of gold nanoparticles and DNAzyme. Analytica Chimica Acta, 1412, 345654. https://doi.org/10.1016/j.aca.2026.345654
Vancouver
Keramati M, Rahaie M. Design and fabrication of a dual-mode colorimetric nanobiosensor for detection of breast cancer-related microRNA biomarkers upon the simultaneous application of gold nanoparticles and DNAzyme. Analytica Chimica Acta. 2026;1412:345654. doi:10.1016/j.aca.2026.345654
BibTeX
@article{Keramati2026,
author = {Keramati, Maryam and Rahaie, Mahdi},
title = {Design and fabrication of a dual-mode colorimetric nanobiosensor for detection of breast cancer-related microRNA biomarkers upon the simultaneous application of gold nanoparticles and DNAzyme},
journal = {Analytica Chimica Acta},
year = {2026},
volume = {1412},
pages = {345654},
doi = {10.1016/j.aca.2026.345654}
}
EUVIMED